UHN selected as Canadian site for CAN-PRIME study, a clinical trial involving Neuralink implant for patients living with cervical spinal cord injury and amyotrophic lateral sclerosis (ALS)
This first-ever procedure in Canada represents an exciting new research direction in neurosurgery and will involve the implantation of a wireless brain-computer ...
CNW
5 days ago
